PRECISEU Matchmaking Platform

20 Oct 2025 – 30 Apr 2026 | Barcelona, Spain

Register
Register
Register

Business OpportunityUpdated on 17 March 2026

Personalized cancer vaccine in TNBC

Direttore scientifico at Neomatrix SRL

roma, Italy

About

Neomatrix has validated in preclinical animal models a personalized cancer vaccine for Triple Negative Breast Cancer (TNBC) in collaboration with Targo TX in UK. We plan to submit a clinical trial authorization for which we are looking for collaboration to transfer the RNA-LNP production process to describe the CMC and submit the CTA to EMA

Stage

  • TRL 6

Topic

  • Bioinformatics
  • Genomics
  • Neoplasms/cancer/oncology

Sector

  • ATMPs
  • Oncology

Type

  • Research collaboration
  • Co-development
  • Clinical validation
  • Regulatory expert

Organisation

Neomatrix SRL

SME

roma, Italy

Similar opportunities